A specific condition · Focused clinical care
Care for abdominal fat changes that fit the diagnosis.
HIV-associated lipodystrophy can raise questions that ordinary weight-loss marketing does not answer. Tesamorelin has a focused approved use in this setting. Understand the distinction, explore the evidence and learn what a clinician would review before treatment. The right conversation begins with the diagnosis and the practical benefits and risks that matter to you.
Specific medical criteria apply · A specialist evaluation or referral may be required.
Specialist evaluations
Clear prices. A clearer next step.
Start with assessment. Confirm specialist costs separately.
The membership price appears alongside the specialist pathway. A medicine-specific quote and specialist eligibility are separate decisions.
Specialist medicine · individual quote required
Tesamorelin specialist medication
Medicine quoted individuallyAfter specialist review · medication separate
A tesamorelin prescription and product-specific patient quote require a specialist assessment. No verified Seine Bio medication price is established here.
Membership does not include tesamorelin or make someone eligible. Approved tesamorelin products have a specific indication; general weight loss or anti-aging is a different question.
Discuss my care optionsPrice sources & what is included
Official product information is linked below. The membership amount is a separate Seine Bio offer; no specialist medication price is quoted here.
Optional product-savings membership
Start with a personal care conversation.
$20Per month · Cancel anytime
- 2% off products; therapy services and membership dues excluded
- Free two-business-day shipping after dispatch on $100+ physical-product orders before discounts and taxes in the contiguous United States
- Cancel anytime to stop future membership renewals
Medication, labs, products and additional treatment cost extra. Care is subject to clinical fit and availability. Membership does not guarantee a prescription, named peptide or research enrollment.
Create a free account ↗The context behind the conversation
Tesamorelin & HIV-Associated Lipodystrophy.
A clearer overview.
Clinical decisions require assessment.
Approved-product information for HIV-associated lipodystrophy. Seine Bio availability is unconfirmed.
The biological question.
Tesamorelin is a growth-hormone-releasing factor analog. It affects pituitary signaling and can increase IGF-1, making laboratory and clinical monitoring important. EGRIFTA is used to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. That specific purpose differs from obesity treatment, general weight management or an aesthetic promise to remove belly fat. The approved-product indication should remain visible wherever this option is discussed.
The story behind the name.
Tesamorelin entered clinical use through a specific treatment need, rather than a broad healthy-aging indication. Its appearance in general peptide discussions can blur that distinction. FDA approval attaches to the labeled EGRIFTA product and its use; it does not automatically establish approval or lawful compounding of a different vial marketed under the ingredient name. A future service must confirm the exact product and an appropriate treating clinician.
FDA-approved EGRIFTA labeling supports the HIV-associated lipodystrophy indication and explicitly says it is not indicated for weight-loss management. Long-term cardiovascular safety has not been established. The label also describes IGF-1, glucose, malignancy and other considerations. A study or approval in this population should not be generalized to an unrelated wellness audience. EGRIFTA WR and EGRIFTA SV are different formulations and the WR label says they are not substitutable.
Understand the evidence
Understanding doses
and cycles.
A clear reference for your conversation with a clinician.
Dose depends on the exact product, route, indication and individual care plan. These references are educational.
| Preparation / context | Dose reference | Frequency | Duration / cycle | Evidence & source |
|---|---|---|---|---|
| EGRIFTA SV · 2 mg/vial formulation | 1.4 mg | Daily | No fixed 12–26-week cycle specified; continuation requires benefit/risk reassessment. | FDA-approved product labeling Excess abdominal fat in HIV-associated lipodystrophy in adults Read the source |
| EGRIFTA WR · 11.6 mg/vial formulation | 1.28 mg | Daily | No fixed cycle; reassess continuation when visceral fat has not decreased. | FDA-approved product labeling Excess abdominal fat in HIV-associated lipodystrophy in adults Read the source |
Swipe or scroll sideways to see every column. There is no universal peptide cycle. A published trial, a product label and an informal online protocol are different kinds of information.
Sources reviewed October 7, 2026. A dose listed here does not establish availability or suitability through Seine Bio.
Ask about my care optionsA useful conversation includes the limits
Know the concerns.
Understand the criteria.
These are key considerations, not a complete safety assessment.
Risks & uncertainties
What deserves attention.
- Elevated IGF-1
- Fluid retention, arthralgia and carpal tunnel symptoms
- Glucose intolerance or diabetes
- Hypersensitivity and injection-site reactions
- Neoplasm concerns; active malignancy is contraindicated
- Pregnancy and specified hypothalamic-pituitary disruption are contraindications
Clinical & regulatory context
Where this pathway fits.
- The assessment should concern adults with HIV-associated lipodystrophy and the relevant abdominal fat change.
- Review malignancy history, glucose status and hypothalamic-pituitary conditions.
- Pregnancy and specific contraindications need careful attention.
- Confirm formulation, supply, follow-up and the clinician’s experience with this condition.
A thoughtful way forward
Make the next step a clear one.
Begin with your questions.
Read about the approved indication and its limitations.
Understand the evidence.
Ask about a focused assessment or specialist referral.
Clarify your next step.
Discuss a monitoring plan and exact treatment cost if the option fits your clinical needs.
Specific medical criteria apply · A specialist evaluation or referral may be required.
Create a free account ↗Clear answers before you decide
Your questions.
A clearer starting point.
Take a moment to understand the practical differences, limits and next steps.
Is this an ordinary belly-fat treatment?
No. EGRIFTA’s approved indication is reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight-loss management. That distinction is part of the service information, not a footnote.
Will this replace an HIV care team?
No. A treatment discussion needs the relevant clinical history and coordination with appropriate care. This page provides focused information and a possible assessment path; it does not establish a prescription or a specialist service at Seine Bio.
Are all tesamorelin vials equivalent?
No. A drug name does not establish product approval, formulation equivalence or lawful sourcing. Even EGRIFTA WR and SV have formulation-specific differences. The actual product and its label matter to the prescribing and monitoring discussion.
Why is follow-up important?
Tesamorelin can affect IGF-1 and glucose and has other relevant warnings. A clinician needs to assess response and safety in the context of the indication. The exact plan should be discussed before a patient accepts treatment and its additional cost.
Your next step, made simple
A clearer next step
starts here.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
- Start with your name and contact information
- Confirm the service, clinical scope and costs
- Complete private clinical intake with the care team
An inquiry does not reserve an appointment, guarantee a prescription or confirm program or clinical-trial availability. No payment with your inquiry.
Start with a free account.
Optional membership: $20/month.
Optional · $20/month · Cancel anytime. Medications, labs, products, additional therapy and separately priced treatments cost extra.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
Please keep medical history, medications and sensitive personal details for private clinical intake.
Read beyond the headline
The sources.
Your own closer look.
Follow the original research, prescribing information and official regulatory sources used for this page.
Reviewed October 7, 2026. Evidence and regulatory status can change.
Your next step.Understand your options first.
Create a free accountIndividual care decisions belong to a licensed clinician. Program information does not guarantee a prescription, named compound, appointment, clinical-trial enrollment or product availability. Clinical care requires appropriate licensing, assessment and follow-up. Membership does not replace clinical eligibility.
We do not provide emergency services. For immediate danger or a medical emergency, call 911. For a mental health crisis in the U.S., call or text 988.
Lifestyle imagery is illustrative, not a patient testimonial.